Ifosfamide and Bleeding disorders - a phase IV clinical study of FDA data

Summary:

Bleeding disorders is reported as a side effect among people who take Ifosfamide (ifosfamide), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Etoposide, and have Bone sarcoma.

The phase IV clinical study analyzes which people have Bleeding disorders when taking Ifosfamide. It is created by eHealthMe based on reports of 21,274 people who have side effects when taking Ifosfamide from the FDA, and is updated regularly.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.

What is Bleeding disorders?

Bleeding disorders is found to be associated with 1,196 drugs and 1,648 conditions by eHealthMe. Check the latest studies of Bleeding disorders.

On Jul, 27, 2026

21,274 people reported to have side effects when taking Ifosfamide.
Among them, 57 people (0.27%) have Bleeding disorders.

Could Ifosfamide cause Bleeding disorders?

Among these 57 people:

How long have people been on Ifosfamide when they have Bleeding disorders? *

What is the gender of people who have Bleeding disorders when taking Ifosfamide? *

female: 39.22 %
male: 60.78 %

What is the age of people who have Bleeding disorders when taking Ifosfamide? *

What are other drugs people take besides Ifosfamide? *

What are other side effects people have besides Bleeding disorders? *

Acute Kidney Failure: 32 people, 56.14%
Hepatotoxicity (chemical-driven liver damage): 23 people, 40.35%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 14 people, 24.56%
Infection: 12 people, 21.05%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 12 people, 21.05%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 11 people, 19.30%
Hypertriglyceridaemia (excess of triglycerides in the blood): 10 people, 17.54%
Bone Marrow Failure: 10 people, 17.54%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 10 people, 17.54%
Electrolyte Imbalance: 10 people, 17.54%

What are the existing conditions these people have? *

Bone Sarcoma (bone cancer): 12 people, 21.05%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 10 people, 17.54%
Respiratory Syncytial Virus Infection (viral disease of respiratory system): 8 people, 14.04%
Angiocentric Lymphoma (extra nodal natural killer cell cancer): 5 people, 8.77%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 8.77%
B Precursor Type Acute Leukaemia (lymphoid cancer): 5 people, 8.77%
Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 4 people, 7.02%
Angioimmunoblastic T-Cell Lymphoma (mature t-cell cancer of the blood or lymph vessel): 4 people, 7.02%
Hepatosplenic T-Cell Lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow): 4 people, 7.02%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 7.02%

* Approximation only. Some reports may have incomplete information.

Do you take Ifosfamide and have Bleeding disorders?

- Check whether Bleeding disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ifosfamide:

Ifosfamide (21,285 reports)

Browse all side effects of Ifosfamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding disorders:

Bleeding disorders (1,196 drugs)

Browse all the conditions that are associated with Bleeding disorders:

Bleeding disorders (1,648 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ifosfamide (the active ingredients of Ifosfamide) and Ifosfamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.